UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
|X| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2007
OR
|_| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________________ to ________________
Commission file number: 001-32361
METROPOLITAN HEALTH NETWORKS, INC.
(Exact name of registrant as specified in its charter)
Florida 65-0635748
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
250 Australian Avenue, Suite 400
West Palm Beach, FL 33401
(Address of principal executive offices) (Zip Code)
(561) 805-8500 (Registrant's
telephone number, including area code)
None
(Former name, former address and former fiscal year, if changed since last
report)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes [X] No [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an
accelerated filer, or a non-accelerated filer. See definition of "accelerated
filer and large accelerated filer" in Rule 12b-2 of the Exchange Act.
Large accelerated filer [ ] Accelerated filer [X] Non-accelerated filer [ ]
Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act).
Yes [ ] No [X]
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
Class Outstanding at October 31, 2007
----------------------------------------- -----------------------------------
Common Stock, $.001 par value per share 51,188,660 shares
Metropolitan Health Networks, Inc.
Index
Part I. FINANCIAL INFORMATION Page
Item 1. Condensed Consolidated Financial Statements (Unaudited):
Condensed Consolidated Balance Sheets
as of September 30, 2007 and December 31, 2006 3
Condensed Consolidated Statements of
Income for the Nine Months and Three Months Ended
September 30, 2007 and 2006 4
Condensed Consolidated Statements of
Cash Flows for the Nine Months Ended
September 30, 2007 and 2006 5
Notes to Condensed Consolidated
Financial Statements 6
Item 2. Management's Discussion and Analysis of
Financial Condition and Results of
Operations 13
Item 3. Quantitative and Qualitative Disclosures About Market Risk 31
Item 4. Controls and Procedures 31
PART II. OTHER INFORMATION 32
Item 1A Risk Factors 32
Item 6. Exhibits 32
SIGNATURES 34
2
PART 1. FINANCIAL INFORMATION
Item 1. Financial Statements
METROPOLITAN HEALTH NETWORKS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
==============================================================================================================================
ASSETS September 30, 2007 December 31, 2006
(unaudited)
------------------ ------------------
CURRENT ASSETS
Cash and equivalents, including $15.7 million in 2007 and $12.5 million in
2006 stautorily limited to use by the HMO $ 34,375,327 $ 23,110,042
Accounts receivable, net of allowance of $93,000 in 2007 and $601,000 in 2006 673,576 674,709
Due from Humana, net of allowance of $1.6 million in 2006 2,347,082 2,970,821
Inventory, primarily medical supplies 372,043 284,777
Prepaid expenses 784,366 706,390
Deferred income taxes 1,571,500 1,600,000
Other current assets 713,698 1,118,099
------------------ ------------------
TOTAL CURRENT ASSETS 40,837,592 30,464,838
Property and equipment, net 2,180,967 2,275,105
Investments 688,997 688,997
Goodwill 1,992,133 1,992,133
Deferred income taxes 3,885,000 5,767,000
Other assets 1,626,253 652,960
------------------ ------------------
TOTAL ASSETS $ 51,210,942 $ 41,841,033
================== ==================
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable $ 858,891 $ 887,174
Accrued payroll and payroll taxes 2,594,960 1,810,428
Estimated medical expenses payable 6,376,699 4,743,737
Due to Centers for Medicare and Medicaid Services 4,509,845 2,702,825
Accrued expenses 1,912,149 767,606
------------------ ------------------
TOTAL CURRENT LIABILITIES 16,252,544 10,911,770
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Preferred stock, par value $.001 per share; stated value $100 per share;
10,000,000 shares authorized; 5,000 issued and outstanding 500,000 500,000
Common stock, par value $.001 per share; 80,000,000 shares authorized;
51,115,660 in 2007 and 50,268,964 in 2006 issued and outstanding 51,116 50,269
Additional paid-in capital 42,561,565 41,453,311
Accumulated deficit (8,154,283) (11,074,317)
------------------ ------------------
TOTAL STOCKHOLDERS' EQUITY 34,958,398 30,929,263
------------------ ------------------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 51,210,942 $ 41,841,033
================== ==================
The accompanying notes are an integral part of the condensed consolidated
financial statements.
3
METROPOLITAN HEALTH NETWORKS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
=============================================================================================================================
Nine Months Ended September 30, Three Months Ended September 30,
2007 2006 2007 2006
(unaudited) (unaudited) (unaudited) (unaudited)
------------- ------------- ------------- -------------
REVENUE $ 207,660,167 $ 172,486,412 $ 69,622,067 $ 60,838,341
MEDICAL EXPENSE
Medical claims expense 173,525,324 145,122,834 57,715,133 49,724,990
Medical center costs 8,269,186 7,621,595 2,789,485 2,530,253
------------- ------------- ------------- -------------
Total Medical Expense 181,794,510 152,744,429 60,504,618 52,255,243
------------- ------------- ------------- -------------
GROSS PROFIT 25,865,657 19,741,983 9,117,449 8,583,098
OPERATING EXPENSES
Payroll, payroll taxes and benefits 10,100,668 7,566,110 3,357,216 2,536,125
Marketing and advertising 2,609,517 2,216,865 577,815 203,403
Restructuring expenses 583,000 -- 583,000 --
General and administrative 8,242,227 5,555,162 2,588,784 2,080,325
------------- ------------- ------------- -------------
Total Operating Expenses 21,535,412 15,338,137 7,106,815 4,819,853
------------- ------------- ------------- -------------
OPERATING INCOME 4,330,245 4,403,846 2,010,634 3,763,245
OTHER INCOME (EXPENSE):
Interest income 1,083,978 731,915 376,732 305,792
Other income (expense) (20,754) 5,312 (3,533) 193
------------- ------------- ------------- -------------
Total other income (expense) 1,063,224 737,227 373,199 305,985
INCOME BEFORE INCOME TAX EXPENSE 5,393,469 5,141,073 2,383,833 4,069,230
INCOME TAX EXPENSE 2,037,000 1,948,200 786,600 1,537,200
------------- ------------- ------------- -------------
NET INCOME $ 3,356,469 $ 3,192,873 $ 1,597,233 $ 2,532,030
============= ============= ============= =============
NET EARNINGS PER COMMON SHARE:
Basic $ 0.07 $ 0.06 0.03 $ 0.05
============= ============= ============= =============
Diluted $ 0.06 $ 0.06 $ 0.03 $ 0.05
============= ============= ============= =============
The accompanying notes are an integral part of the condensed consolidated
financial statements.
4
METROPOLITAN HEALTH NETWORKS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
=================================================================================================
Nine Months Ended September 30,
2007 2006
(unaudited) (unaudited)
------------ ------------
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income $ 3,356,469 $ 3,192,873
Adjustments to reconcile net income to net cash
provided by/(used in) operating activities:
Depreciation and amortization 645,835 378,801
Loss on disposal of fixed assets 72,000
Stock-based compensation expense 547,860 545,983
Shares issued for director fees 65,032 --
Excess tax benefits from share based compensation (245,000) --
Amortization of securities issued for professional services -- 57,300
Deferred income taxes 1,718,500 1,948,200
Other -- 191
Changes in operating assets and liabilities:
Accounts receivable 624,872 (89,222)
Inventory (87,266) (43,613)
Prepaid expenses (77,976) (575,823)
Other current assets 397,328 115,790
Other assets (4,716) (25,381)
Accounts payable (28,283) 167,653
Accrued payroll and payroll taxes 784,532 21,598
Estimated medical expenses payable 1,632,962 3,422,773
Due to Centers for Medicare and Medicaid Services 1,807,020 1,298,153
Accrued expenses 769,542 527,779
------------ ------------
Net cash provided by operating activities 11,978,711 10,943,055
CASH FLOWS FROM INVESTING ACTIVITIES:
Short-term investments -- (5,769,955)
Investments -- (35,224)
Cash paid for physician practice acquisition (591,205) --
Capital expenditures (616,624) (1,546,991)
------------ ------------
Net cash used in investing activities (1,207,829) (7,352,170)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of stock options 249,403 140,750
Excess tax benefits from share based compensation 245,000 --
------------ ------------
Net cash provided by financing activities 494,403 140,750
------------ ------------
NET INCREASE IN CASH AND EQUIVALENTS
11,265,285 3,731,635
CASH AND EQUIVALENTS - beginning of period 23,110,042 15,572,862
------------ ------------
CASH AND EQUIVALENTS - end of period $ 34,375,327 $ 19,304,497
============ ============
Supplemental Schedule of Non-Cash Financing Activities
Issuance of note payable for physician practice
acquisition $ 375,000 $ --
============ ============
The accompanying notes are an integral part of the condensed consolidated
financial statements.
5
METROPOLITAN HEALTH NETWORKS, INC. & SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 1 UNAUDITED INTERIM INFORMATION
The accompanying unaudited condensed consolidated financial statements of
Metropolitan Health Networks, Inc. and subsidiaries (referred to as
"Metropolitan," "the Company," "we," "us," or "our") have been prepared in
accordance with accounting principles generally accepted in the United States
for interim financial information and with the instructions to Form 10-Q and
Article 10 of Regulation S-X. Accordingly, they do not include all of the
information and footnotes required by accounting principles generally accepted
in the United States of America for complete financial statements, or those
normally made in an Annual Report on Form 10-K. In the opinion of management,
all adjustments (consisting of normal recurring accruals) considered necessary
for a fair presentation have been included. Operating results for the nine month
period and three month period ended September 30, 2007 are not necessarily
indicative of the results that may be reported for the remainder of the year
ending December 31, 2007 or future periods.
The preparation of our condensed consolidated financial statements in accordance
with accounting principles generally accepted in the United States of America
requires us to make estimates and assumptions that affect the amounts reported
in the condensed consolidated financial statements and accompanying notes. The
areas involving the most significant use of estimates are medical expenses
payable, premium revenue, the impact of risk sharing provisions related to our
Medicare contracts and our contracts with Humana, Inc. ("Humana"), amounts in
dispute with Humana, the future benefit of deferred tax assets and the valuation
and related impairment recognition of long-lived assets, including goodwill.
These estimates are based on knowledge of current events and anticipated future
events. We adjust these estimates each period as more current information
becomes available. The impact of any changes in estimates is included in the
determination of earnings in the period in which the estimate is adjusted.
Actual results may ultimately differ materially from those estimates.
For further information, refer to the audited consolidated financial statements
and footnotes thereto included in the Company's Annual Report on Form 10-K for
the year ended December 31, 2006. The accompanying December 31, 2006 condensed
consolidated balance sheet has been derived from these audited financial
statements. These interim condensed consolidated financial statements should be
read in conjunction with the audited consolidated financial statements and notes
to consolidated financial statements included in that report.
Certain reclassifications have been made to the 2006 income statement captions
to conform to the current period presentation.
NOTE 2 ORGANIZATION AND BUSINESS ACTIVITY
We own and operate provider service networks through our wholly owned
subsidiary, Metcare of Florida, Inc. (the "PSN"). We also operate a health
maintenance organization (the "HMO") through our wholly owned subsidiary,
METCARE Health Plans, Inc.
The PSN operates under two agreements (the "Humana Agreements") with Humana, one
of the largest participants in the Medicare Advantage program in the United
States, to provide medical care to Medicare beneficiaries enrolled under
Humana's health plans. To deliver care, we utilize our wholly-owned medical
practices and have also contracted directly or indirectly through Humana with
third-party medical practices, service providers and hospitals (collectively the
"Affiliated Providers"). The PSN operates in South Florida and Central Florida.
Effective as of August 1, 2007, the PSN entered into a network agreement (the
"CarePlus Agreement") with CarePlus Health Plans, Inc., a Medicare Advantage
health plan in Florida. CarePlus is a wholly-owned subsidiary of Humana.
Pursuant to the CarePlus Agreement, the PSN will provide, on a non-exclusive
basis, healthcare services to Medicare beneficiaries in nine Florida counties.
Effective July 1, 2005, the HMO became licensed and entered into a contract with
the Centers for Medicare and Medicaid Services ("CMS") to begin offering
Medicare Advantage plans to Medicare beneficiaries in nine Florida counties. The
HMO began operating and marketing its "AdvantageCare" branded plan in July 2005.
Beginning January 1, 2007, the HMO began to offer plans in 12 counties in
Florida. In July 2007, the HMO was approved to begin operating in Collier
County, Florida commencing January 1, 2008. The HMO's agreement with CMS is
generally renewable for a one-year term each December 31 unless CMS notifies the
HMO of its decision not to renew the agreement by May 1 of the contract year, or
the HMO notifies CMS of its decision not to renew by the first Monday in June of
the contract year. Neither we nor CMS provided the other party with a
non-renewal notice.
6
We manage the PSN and HMO as separate business segments.
NOTE 3 SIGNIFICANT ACCOUNTING POLICIES
On January 1, 2007, we adopted the provision of Financial Accounting Standards
Board ("FASB") Interpretation No. 48, Accounting for Uncertainty in Income Taxes
("Interpretation No. 48"). Previously, we had accounted for tax contingencies in
accordance with Statement of Financial Accounting Standards ("SFAS") No. 5,
Accounting for Contingencies. As required by Interpretation No. 48, which
clarifies SFAS Statement No. 109, Accounting for Income Taxes, we recognize the
financial statement benefit of a tax position only after determining that the
relevant tax authority would more-likely-than-not sustain the position following
an audit. We have considered the effects of the FASB Staff Position ("FSP")
amending Interpretation No. 48 and have considered this FSP as if it were
adopted at the implementation date of Interpretation No. 48. For tax positions
meeting the more-likely-than-not threshold, the amount recognized in the
financial statements is the largest benefit that has a greater than 50%
likelihood of being realized upon ultimate settlement with the relevant tax
authority. As a result of the adoption of Interpretation No. 48, we derecognized
certain deferred tax assets totaling approximately $437,000, which was accounted
for as an addition to the accumulated deficit at January 1, 2007. In the third
quarter of 2007, we recognized tax benefits of $120,000 upon the expiration of
the statute of limitations applicable to the tax years during which the benefits
were generated.
We are subject to income taxes in the U.S. federal jurisdiction and the state of
Florida. Tax regulations are subject to interpretation of the related tax laws
and regulations and require significant judgment to apply. We have net operating
loss carry forwards related to years prior to 2003. To the extent such net
operating losses are utilized, the years from which the loss carryforwards
originate are open for examination by the relevant taxing authorities. Upon
adoption of Interpretation No. 48, we evaluated our tax positions with regard to
these years. The statute of limitations for the federal and Florida 2004 tax
years will expire in the next twelve months.
The Internal Revenue Service is presently examining our 2005 Federal income tax
return. We do not expect to recognize a significant change to the total amount
of unrecognized tax benefit as a result of the examination.
We recognize interest related to unrecognized tax benefits in interest expense,
which is included in other income (expense) in the condensed consolidated
statements of income, and penalties in operating expenses for all periods
presented. No interest has been accrued in the third quarter of 2007 and $25,000
of interest has been accrued for the nine months ended September 30, 2007. No
penalties have been accrued in any period presented.
NOTE 4 RECENT ACCOUNTING PRONOUNCEMENTS
In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements, which
defines fair value, establishes a framework for measuring fair value pursuant to
generally accepted accounting principles, and expands disclosures about fair
value measurements. SFAS No. 157 does not require any new fair value
measurements, but provides guidance on how to measure fair value by providing a
fair value hierarchy used to classify the source of the information. This
statement is effective for fiscal years beginning after November 15, 2007. We
are currently assessing the potential impact, if any, that the adoption of SFAS
No. 157 will have on our financial statements.
SFAS No. 159, The Fair Value Option for Financial Assets and Financial
Liabilities, Including an amendment of FASB Statement No. 115 issued in February
2007, allows entities to voluntarily choose to measure many financial assets and
financial liabilities at fair value through earnings. Upon initial adoption,
SFAS No. 159 provides entities with a one-time chance to elect the fair value
option for existing eligible items. The effect of the first measurement to fair
value is reported as a cumulative-effect adjustment to the opening balance of
retained earnings in the year SFAS No. 159 is adopted. SFAS No. 159 is effective
as of the beginning of fiscal years starting after November 15, 2007. We are
currently assessing the potential impact, if any, that the adoption of SFAS No.
159 will have on our financial statements.
7
NOTE 5 REVENUE
Our Medicare premium revenue is adjusted periodically to give effect to a risk
component. Risk adjustment uses health status indicators to improve the accuracy
of payments and establish incentives for plans to enroll and treat less healthy
Medicare beneficiaries. Under the risk adjustment methodology, managed care
plans must capture, collect, and submit diagnosis code information to CMS. After
reviewing the respective submissions, CMS generally adjusts the premium payments
to Medicare plans at the beginning and middle of the calendar year and performs
a final settlement in the subsequent year.
In June 2007, the HMO was notified of a 2007 mid-year retroactive Medicare Risk
Adjustment ("MRA") increase from CMS based on the increased medical risk scores
of the HMO's customer base. This increase was made effective July 1 and was
retroactively applied to all premiums paid in the first half of 2007. As a
result of this increase, the HMO realized additional revenue of $781,000 in the
2007 second quarter. Premiums for the balance of 2007 are being paid based on
the new medical risk scores. Included in the HMO's revenue for the third quarter
of 2006 was a risk score adjustment for the first six months of 2006 of
$534,000.
In July 2007, we received the final MRA increase for 2006 premiums paid by CMS
to the HMO of $575,000. This amount is $340,000 higher than our recorded
estimate at December 31, 2006 of $235,000. The $340,000 was recorded in revenue
in the second quarter of 2007.
In the third quarter of 2006, the PSN realized revenue of $763,000 as a result
of the mid-year MRA increase for 2006. The mid-year MRA increase for the PSN for
2007 was recognized during the first half of 2007.
NOTE 6 MEDICAL EXPENSE
Total medical expense for both the PSN and HMO is recognized in the period in
which services are provided and includes an estimate of our obligations for
medical services that have been provided to our customers but for which we have
either not yet received or processed claims, and for liabilities for physician,
hospital and other medical expense disputes. We estimate liabilities for
physician, hospital and other medical expense disputes based upon an analysis of
potential outcomes, assuming a combination of litigation and settlement
strategies. We develop our estimated medical claims payable by using an
actuarial process that is consistently applied. The actuarial process and models
develop a range of estimated medical claims payable and we record to the amount
in the range that is our best estimate of the ultimate liability.
Each period, we re-examine previously established medical claims payable
estimates based on actual claim submissions and other changes in facts and
circumstances. As the liability estimate recorded in prior periods becomes more
exact, we adjust the amount of our liability estimate, and include the change in
medical expense in the period in which the change is identified. In each
reporting period, our operating results include the effects of more completely
developed medical expense payable estimates associated with previously reported
periods. While we believe our estimated medical expenses payable is adequate to
cover future claims payments required, such estimates are based on claims
experience to date and various assumptions. Therefore, the actual liability
could differ materially from the amount recorded.
At September 30, 2007, we determined that the range for estimated medical
expenses payable for the PSN was between $13.4 million and $14.5 million and we
recorded a liability at the mid-range of $13.9 million. This amount is included
within the due from Humana in the accompanying condensed consolidated balance
sheets.
At September 30, 2007, we estimated that the range for estimated medical claims
payable for the HMO was between $6.4 million and $7.4 million and we recorded a
liability of $6.4 million. Based on historical results, we believe that, for the
HMO, the low end of the range continues to be the best estimate of the ultimate
liability.
NOTE 7 DRUG COSTS
Through the Medicare Drug, or Part D, program the PSN, through Humana, and the
HMO receive premiums from CMS to cover the cost of certain prescription drugs
utilized by our customers. Under the Part D program, if a plan's margins are
outside of a prescribed corridor, a portion of the difference is ultimately
refunded back to CMS. Similarly, if the plan generates costs in excess of the
premiums, a portion of the loss is charged back to CMS. Throughout the year, for
both our HMO and PSN we estimate the amounts to be received from or refunded to
CMS in connection with the Part D program final settlement. Since these amounts
represent additional premium or premium that is to be returned, any adjustment
is recorded as an increase or decrease to revenue. The final settlement for the
Part D program occurs in the subsequent year.
8
In October 2007, CMS notified the HMO that the HMO must refund approximately
$2.7 million back to CMS for excess Part D premium payments in 2006. At December
31, 2006, the HMO had accrued approximately $2.7 million for this refund. The
monies will be recouped by CMS in the fourth quarter of 2007. At September 30,
2007, we have accrued a liability of $1.8 million for the estimated 2007 Part D
liability. These amounts are shown as due to CMS in the accompanying condensed
consolidated balance sheets.
At June 30, 2007, we estimated the PSN would have no liability for excess Part D
payments related to 2007 premiums. At September 30, 2007, based on year to date
drug costs and utilization patterns and changes in actuarial assumptions
underlying future drug costs projections, we determined that a liability for
Part D premium payments in excess of drug costs of approximately $3.0 million
should be recorded, of which approximately $2 million relates to premiums
received in prior quarters. This amount is included within Due From Humana in
the accompanying condensed consolidated balance sheet. Accordingly, we reduced
revenue in the third quarter and accrued a liability for $3.0 million at
September 30, 2007. We anticipate that this change in the Part D estimate will
also reduce the PSN's revenue in the fourth quarter of 2007 by approximately $1
million.
At December 31, 2006, the PSN had recorded a liability for the estimated 2006
Part D settlement. Based upon CMS' final determination in October 2007 of Part D
costs incurred by the PSN in 2006, we recorded additional revenue in the third
quarter of 2007 of approximately $1.0 million, representing the amount by which
our 2006 year-end estimated Part D refund liability exceeded the final amount.
NOTE 8 RESTRUCTURING EXPENSES AND SEPARATION
As part of our continuing efforts to enhance our profitability, in July 2007, we
implemented a restructuring plan designed to reduce costs and improve operating
efficiencies. The restructuring plan, completed by the end of August 2007,
resulted in the closure of two of the HMO's office locations, one PSN medical
practice (the "PSN Practice"), and a workforce reduction involving 16 employees.
In connection with this plan, we recorded approximately $583,000 of
restructuring costs during the third quarter of 2007 including approximately
$147,000 for severance payments, approximately $364,000 for continuing lease
obligations on closed locations and approximately $72,000 for the write-off of
certain leasehold improvements and equipment. During the third quarter of 2007,
we made cash payments related to the restructuring of $191,000. The severance
payments and continuing lease obligations will result in additional future cash
expenditures. We believe that the restructuring will enable us to reduce our
related operating expenses by approximately $1.2 million per annum, with no or
limited impact on the HMO's and PSN's ability to serve their existing customers.
At the time of its closure on July 31, 2007, the PSN Practice served
approximately 450 customers in South Florida, all of which were moved to other
providers outside of the PSN. Prior to its closing on July 31, the PSN practice
generated approximately $2.6 million of revenue in 2007 and had a negative gross
margin. Of the $583,000 restructuring charge, approximately $400,000 relates to
the HMO with the balance of $183,000 associated with the PSN.
The remaining severance payments associated with the restructuring will
primarily occur in the fourth quarter of 2007. Certain cash payments associated
with lease terminations could be paid over the remaining lease terms.
A summary of the restructuring activity during the third quarter of 2007 is as
follows:
Restructuring costs accrued in third quarter of 2007 $583,000
Cash paid in third quarter of 2007 191,000
--------
Balance at September 30, 2007 $392,000
========
On April 9, 2007 ("Separation Date"), we entered into a mutually agreeable
separation agreement (the "Separation Agreement") with the individual who served
as our President and Chief Operating Officer until the Separation Date. Under
the Separation Agreement, we agreed, among other things, to provide this
individual with her base salary, to allow her to participate in certain of our
benefit programs and to provide her with an automobile and mobile phone
allowance for twelve months following the separation date. Under the Separation
Agreement, this individual has agreed to be bound by restrictive covenants
regarding, among other things, non-competition with us for a one-year period,
non-solicitation of our employees for a two-year period and confidentiality. In
the second quarter of 2007, we accrued approximately $500,000 related to the
amount payable under the Separation Agreement and the value of certain options
held by this individual that, in accordance with their terms, became fully
vested on the Separation Date, subject to a three-month exercise period.
9
On June 26, 2007, we entered in to an agreement with this individual, to
repurchase for $10,000 options she held to purchase 800,000 shares of our common
stock with an exercise price of $1.83 per share. This amount has been reflected
as a reduction of additional paid-in capital.
NOTE 9 INCOME TAXES
The effective income tax rate was 33.0% for the three months ended September 30,
2007 compared to 37.8% for the three months ended September 30, 2006. The
decrease in the effective income tax rate in 2007 is a result of an approximate
$120,000 tax benefit which had been reserved and is now being recognized upon
the expiration of the statute of limitations for the tax period to which the
benefit relates.
For the nine months ended September 30, 2007 and 2006, the effective income tax
rate was 37.8% and 37.9%, respectively.
NOTE 10 EARNINGS PER SHARE
Earnings per common share, basic is computed using the weighted average number
of common shares outstanding during the period. Earnings per common share,
diluted is computed using the weighted average number of common shares
outstanding during the period adjusted for incremental shares attributed to
outstanding options and warrants, nonvested stock and preferred stock
convertible into shares of common stock.
Nine months ended September 30, Three months ended September 30,
2007 2006 2007 2006
------------- ------------- ------------- -------------
Net income $ 3,356,000 $ 3,193,000 $ 1,597,000 $ 2,532,000
Less: Preferred stock dividend (38,000) (38,000) (13,000) (13,000)
------------------------------ ------------------------------
Income available to common stockholders $ 3,318,000 $ 3,155,000 $ 1,584,000 $ 2,519,000
============================== ==============================
Denominator:
Weighted average common shares outstanding 50,434,000 49,981,000 50,714,000 50,108,000
============= ============= ============= =============
Basic earnings per common share $ 0.07 $ 0.06 $ 0.03 $ 0.05
============= ============= ============= =============
Income available to common stockholders, diluted basis $ 3,318,000 $ 3,155,000 $ 1,597,000 $ 2,532,000
============= ============= ============= =============
Denominator:
Weighted average common shares outstanding 50,434,000 49,981,000 50,714,000 50,108,000
Common share equivalents of outstanding stock:
Convertible preferred stock -- -- 632,000 437,000
Nonvested stock 110,000 -- 273,000 --
Options and warrants 1,075,000 1,402,000 794,000 1,494,000
------------- ------------- ------------- -------------
Weighted average common shares outstanding 51,619,000 51,383,000 52,413,000 52,039,000
============= ============= ============= =============
Diluted earnings per common share $ 0.06 $ 0.06 $ 0.03 $ 0.05
============= ============= ============= =============
Weighted average of antidilutive stock options 718,000 455,000 954,000 356,000
============= ============= ============= =============
Weighted average of antidilutive convertible preferred stock 355,000 496,000 -- --
============= ============= ============= =============
10
NOTE 11 STOCKHOLDERS' EQUITY
During the three months ended September 30, 2007, we issued 240,100 shares of
common stock in connection with the exercise of stock options. During the nine
month period ended September 30, 2007, we issued 495,900 shares of common stock
in connection with the exercise of stock options.
In connection with the 2006 bonus plan, during the 2007 third quarter we issued
193,500 restricted shares and options to purchase 482,500 shares of common stock
to employees. The restricted shares and stock options vest in equal annual
installments over a four year period from the date of grant. The options, which
vest in equal annual installments over a four year period from the date of
grant, have an exercise price equal to the closing price of our common stock on
the day preceding the grant date. Compensation expense related to the restricted
stock and options is recognized ratably over the vesting period.
During the 2007 third quarter, we also issued options to a consultant to
purchase 100,000 shares of our common stock. These options, which fully vest on
December 31, 2007 and expire on June 30, 2008, have an exercise price equal to
the closing price of our common stock on the day preceding the grant date. The
expense related to the restricted options is recognized ratably over the vesting
period.
In addition, during the nine month period ended September 30, 2007, we awarded
an aggregate of 157,296 restricted shares of our common stock and options to
purchase 78,648 shares of our common stock to the non-employee members of our
Board of Directors. The options have an exercise price equal to the closing
price of our common stock on the day preceding the grant date. These restricted
shares and stock options are scheduled to vest on the first anniversary of the
date of grant. Compensation expense related to the restricted shares and stock
options is recognized ratably over the vesting period.
NOTE 12 COMMITMENTS AND CONTINGENCIES
Legal Proceedings
On March 13, 2007, a complaint was filed by Mr. Noel Guillama, who served as our
President, Chairman of the Board and Chief Executive Officer from January 1996
through February 2000, in the Circuit Court of the Fifteenth Judicial Circuit in
and for Palm Beach County, naming us as a defendant. The dispute involves
1,500,000 restricted shares of common stock issued to Mr. Guillama in connection
with his personal guarantee of a Company line of credit in 1999. We repaid the
line of credit and expected, based on documentation signed by Mr. Guillama, the
1,500,000 shares issued as collateral to be returned to us. Mr. Guillama alleges
that we have breached an agreement to remove the transfer restrictions from
these shares and is seeking damages for breach of contract and specific
performance. We believe this lawsuit is without merit and intend to assert an
appropriate defense. We filed a motion to dismiss the complaint in May 2007.
These shares have not been reflected as issued or outstanding in the
accompanying condensed consolidated balance sheets or in the computations of
earnings per share.
We are also a party to certain other claims arising in the ordinary course of
business. We believe that the outcome of these matters will not have a material
adverse effect on our financial position or the results of our operations.
Guarantees
In connection with the sale of the assets of our pharmacy division in 2003, the
purchaser of the pharmacy assets agreed to assume our obligation under a lease
which ran through 2012. In the event of the purchaser's default, we could be
responsible for future lease payments totaling approximately $582,000 at
September 30, 2007.
NOTE 13 PHYSICIAN PRACTICES
Effective July 31, 2007, we acquired certain assets of one of our contracted
independent primary care physician practices in the Central Florida market for
approximately $875,000, plus transaction costs of approximately $91,000. This
transaction has been accounted for as a purchase of assets. We are currently in
the process of determining the allocation of the purchase price among the assets
acquired. At September 30, 2007, the purchase price has been included in other
assets.
In addition, the PSN opened a medical center in its Central Florida market on
November 1, 2007.
11
NOTE 14 BUSINESS SEGMENT INFORMATION
We manage the PSN and HMO as separate business segments. We identified our
segments in accordance with the aggregation provisions of SFAS No. 131,
Disclosures about Segments of an Enterprise and Related Information, which is
consistent with information used by our Chief Executive Officer in managing our
business. The segment information aggregates products with similar economic
characteristics. These characteristics include the nature of customer groups and
the nature of the services and benefits provided. The results of each segment
are measured by income before income taxes. We allocate all selling, general and
administrative expenses, investment and other income, interest expense, goodwill
and certain other assets and liabilities to our segments. Our segments do share
overhead costs.
NINE MONTHS ENDED SEPTEMBER 30, 2007 PSN HMO Total
-------------------------------------------------------------- ------------- ------------- -------------
Revenues from external customers $ 169,371,000 $ 38,289,000 $ 207,660,000
Segment gain (loss) before allocated overhead and income taxes 21,134,000 (8,668,000) 12,466,000
Allocated corporate overhead 3,534,000 3,539,000 7,073,000
Segment gain (loss) after allocated overhead and before income
taxes 17,600,000 (12,207,000) 5,393,000
Segment assets 30,882,000 14,598,000 45,480,000
Goodwill 1,992,000 -- 1,992,000
NINE MONTHS ENDED SEPTMEBER 30, 2006 PSN HMO Total
-------------------------------------------------------------- ------------- ------------- -------------
Revenues from external customers $ 152,627,000 $ 19,859,000 $ 172,486,000
Segment gain (loss) before allocated overhead and income taxes 16,150,000 (6,218,000) 9,932,000
Allocated corporate overhead 2,732,000 2,059,000 4,791,000
Segment gain (loss) after allocated overhead and before income
taxes 13,418,000 (8,277,000) 5,141,000
Segment assets 22,973,000 16,685,000 39,658,000
Goodwill 1,992,000 -- 1,992,000
THREE MONTHS ENDED SEPTEMBER 30, 2007 PSN HMO Total
-------------------------------------------------------------- ------------- ------------- -------------
Revenues from external customers $ 55,616,000 $ 14,006,000 $ 69,622,000
Segment gain (loss) before allocated overhead and income taxes 8,045,000 (3,117,000) 4,928,000
Allocated corporate overhead 1,347,000 1,197,000 2,544,000
Segment gain (loss) after allocated overhead and before income
taxes 6,698,000 (4,314,000) 2,384,000
THREE MONTHS ENDED SEPTEMBER 30, 2006 PSN HMO Total
-------------------------------------------------------------- ------------- ------------- -------------
Revenues from external customers $ 52,316,000 $ 8,522,000 $ 60,838,000
Segment gain (loss) before allocated overhead and income taxes 7,659,000 (2,049,000) 5,610,000
Allocated corporate overhead 914,000 627,000 1,541,000
Segment gain (loss) after allocated overhead and before income
taxes 6,745,000 (2,676,000) 4,069,000
Segment assets at September 30, 2007 exclude general corporate assets of $6.7
million including deferred tax assets of $5.5 million.
Segment assets at September 30, 2006 exclude general corporate assets of $7.4
million including deferred tax assets of $6.0 million.
12
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
THE FOLLOWING DISCUSSION SHOULD BE READ IN CONJUNCTION WITH OUR ANNUAL REPORT ON
FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2006, AS WELL AS THE FINANCIAL
STATEMENTS AND NOTES THERETO.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
The condensed consolidated financial statements of the Company in this document
present our financial position, results of operations and cash flows, and should
be read in conjunction with the following discussion and analysis. Sections of
this Quarterly Report contain statements that are forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933 (the "Securities
Act") and Section 21E of the Securities Exchange Act of 1934, as amended, (the
"Exchange Act"), and we intend that such forward-looking statements be subject
to the safe harbors created thereby. Statements in this Report containing the
words "estimate," "project," "anticipate," "expect," "intend," "believe,"
"will," "could," "should," "may," and similar expressions may be deemed to
create forward-looking statements. Accordingly, such statements, including
without limitation, those relating to our future business, prospects, revenues,
working capital, liquidity, capital needs, interest costs and income, wherever
they may appear in this document or in other statements attributable to us,
involve estimates, assumptions and uncertainties which could cause actual
results to differ materially from those expressed in the forward-looking
statements.
Specifically, this report contains forward-looking statements, including
the following:
o the PSN's ability to renew its agreements with Humana and maintain
these agreements on favorable terms;
o our ability to adequately predict and control medical expenses and
to make reasonable estimates and maintain adequate accruals for
incurred but not reported ("IBNR") claims; and
o the HMO's ability to renew, maintain and/or to successfully rebid
its agreement with CMS.
The forward-looking statements reflect our current view about future events and
are subject to risks, uncertainties and assumptions. We wish to caution readers
that certain important factors may have affected and could in the future affect
our actual results and could cause actual results to differ significantly from
those expressed in any forward-looking statement. The following important
factors could prevent us from achieving our goals and cause the assumptions
underlying the forward-looking statements and the actual results to differ
materially from those expressed in or implied by those forward-looking
statements:
o reductions in government funding of Medicare programs;
o disruptions in the PSN's, the HMO's or Humana's healthcare provider
networks;
o failure to receive claims processing, billing services, data
collection and other information on a timely basis from Humana or HF
Administrative Services, the third party administrative service
provider for the HMO;
o failure to receive, on a timely or accurate basis, customer
information from CMS;
o future legislation and changes in governmental regulations;
o our ability to grow our HMO customers in our current geographic
markets and our ability to expand our HMO into new geographic
markets;
o increases in our operating costs;
o the impact of Medicare Risk Adjustments on payments we receive from
CMS or Humana;
13
o the impact of the Medicare prescription drug plan on our operations;
o loss of any significant contracts;
o general economic and business conditions;
o increased competition;
o the relative health of our patients;
o changes in estimates and judgments associated with our critical
accounting policies;
o federal and state investigations;
o our ability to successfully recruit and retain key management
personnel and qualified medical professionals; and
o impairment charges that could be required in future periods.
Additional information concerning these and other risks and uncertainties is
contained in our filings with the Securities and Exchange Commission (the
"Commission"), including the section entitled "Risk Factors" in our Annual
Report on Form 10-K for the year ended December 31, 2006.
Forward-looking statements should not be relied upon as a prediction of actual
results. Subject to any continuing obligations under applicable law or any
relevant listing rules, we expressly disclaim any obligation to disseminate,
after the date of this Quarterly Report on Form 10-Q, any updates or revisions
to any such forward-looking statements to reflect any change in expectations or
events, conditions or circumstances on which any such statements are based.
BACKGROUND
We operate two business segments in Florida, the PSN which provides and arranges
for medical care primarily to customers of Humana and the HMO, which provides
healthcare benefits to Medicare beneficiaries in Florida that have selected our
health plan.
Both our PSN and HMO operations primarily focus on individuals covered by
Medicare, the national, federally-administered health insurance program that
covers the cost of hospitalization, medical care, and some related health
services for U.S. citizens aged 65 and older, qualifying disabled persons and
persons suffering from end-staged renal disease.
Substantially all of our revenue for the nine months ended September 30, 2007
and 2006 was generated by providing services to Medicare beneficiaries through
arrangements that require us to assume responsibility to provide and/or manage
the care for all of our customers' medical needs in exchange for a monthly fee,
also known as a capitated fee or capitation arrangement.
Provider Service Network
The PSN has two network contracts (the "Humana Agreements") with Humana, one of
the largest participants in the Medicare Advantage program in the United States.
Our PSN provides, on a non-exclusive basis, healthcare services to Medicare
beneficiaries in Flagler and Volusia counties ("Central Florida") and Palm
Beach, Broward and Miami-Dade counties ("South Florida") who have elected to
receive benefits through Humana's Medicare Advantage Plan. As of September 30,
2007, the Humana Agreements covered approximately 19,000 Humana Plan Customers
(as defined below) in Central Florida and 5,600 Humana Plan Customers in South
Florida. Approximately 81.1% of our revenue during the first nine months of 2007
was generated through the Humana Agreements.
Effective as of August 1, 2007, the PSN entered into a network agreement (the
"CarePlus Agreement") with CarePlus Health Plans, Inc., a Medicare Advantage
health plan in Florida. CarePlus Health Plans, Inc. is a wholly-owned subsidiary
of Humana. Pursuant to the CarePlus Agreement, the PSN will provide, on a
non-exclusive basis, healthcare services to Medicare beneficiaries in nine
Florida counties who have elected to receive benefits through CarePlus' Medicare
Advantage plans. The counties covered by the CarePlus Agreement include the
South Florida counties in which we provide services to Humana Plan Customers
(Palm Beach, Broward and Miami-Dade) as well as Orange, Osceola, Seminole,
Pasco, Pinellas and Hillsborough counties. As of October 1, 2007, the CarePlus
Agreement covered approximately 16 CarePlus Participating Customers (as defined
below).
14
We have built our PSN physician network by contracting with independent primary
care physicians (individually, an "IPA") for their services and by acquiring and
operating our own physician practices (collectively with the IPAs, the "PSN
Physicians").
To service the Humana Participating Customers (as defined below), at September
30, 2007, we had contracts in place with 30 IPAs and we own and operate nine
primary care physician practices and one medical oncology physician practice. In
addition, through our Humana Agreements we have established referral
relationships with a large number of specialist physicians, ancillary service
providers and hospitals throughout South Florida and Central Florida.
Under the CarePlus Agreement, with certain limited exceptions, we are precluded
from using the PSN Physicians who provide services to the Humana Participating
Customers to provide services to CarePlus Participating Customers (as defined
below). Accordingly, the PSN must (i) locate and contract with new IPAs and/or
(ii) acquire or establish and operate its own physician practices to service the
CarePlus Participating Customers. At September 30, 2007, we have contracts in
place with six IPAs to provide services to the CarePlus Participating Customers.
Effective July 31, 2007, the PSN acquired certain assets of one of our IPAs in
the Central Florida market for approximately $966,000. Effective August 1, the
PSN closed a wholly-owned primary care physician practice in South Florida. The
PSN opened an additional primary care physician practice in the Central Florida
market on November 1, 2007.
Humana directly contracts with CMS and is paid a fixed monthly premium payment
for each customer (each a "Humana Plan Customer") enrolled in Humana's Medicare
Advantage Plan. The monthly premium varies by patient, county, age and severity
of health status. Pursuant to the Humana Agreements, the PSN provides or
arranges for the provision of covered medical services to each Humana Plan
Customer who selects one of the PSN Physicians as his or her primary care
physician (a "Humana Participating Customer"). In return for the provision of
these medical services, the PSN receives from Humana a capitated fee for each
Humana Participating Customer. The fee rates are established by the Humana
Agreements and comprise a substantial portion of the monthly premiums received
by Humana from CMS with respect to Humana Participating Customers.
In Central Florida, our PSN assumes full responsibility for the provision of all
necessary medical care for each Humana Participating Customer, even for services
we do not provide directly. In South Florida, the PSN and Humana share in the
cost of inpatient hospital services and the PSN assumes full responsibility for
the provision of all other medical care provided to the Humana Participating
Customer. To the extent the costs of providing such medical care are less than
the related premiums received from Humana, our PSN generates a gross profit.
Conversely, if medical expenses exceed the premiums received from Humana, our
PSN experiences a gross loss.
CarePlus directly contracts with CMS and is paid a fixed monthly premium payment
for each customer (each a "CarePlus Customer") enrolled in CarePlus' Medicare
Advantage Plan. The monthly premium varies by patient, county, age and severity
of health status. Pursuant to the CarePlus Agreement, the PSN provides or
arranges for the provision of covered medical services to each CarePlus Plan
Customer who selects one of the PSN Physicians as his or her primary care
physician (a "CarePlus Participating Customer"). In return for the provision of
these medical services, the PSN will receive a monthly Network Administration
Fee for each CarePlus Participating Customer. The network administration fee is
paid on a per customer, per month basis, and it is a flat rate amount. Upon the
earlier of the number of CarePlus Participating Customers exceeding 500 in a
given calendar month or March 31, 2008, the PSN will begin receiving a capitated
fee for each CarePlus Participating Customer and, in connection therewith, the
PSN will assume full responsibility for the provision of all necessary medical
care for each CarePlus Participating Customer, even for services we do not
provide directly.
Substantially all of our PSN's revenue is generated under the Humana Agreements.
We do receive additional revenue in the medical practices we own and operate by
providing primary care services to non-Humana Participating Customers on a
fee-for-service basis.
15
Health Maintenance Organization
We operate the HMO through METCARE Health Plans, Inc., our wholly owned
subsidiary that was issued a Health Care Provider Certificate ("HCPC") by
Florida's Agency for Health Care Administration ("AHCA") on March 16, 2005. The
Department of Financial Services, Office of Insurance Regulation ("OIR")
approved the HMO's application and issued a Certificate of Authority to operate
a HMO in the State of Florida ("COA") on April 22, 2005. The HMO recorded its
first revenue in the third quarter of 2005.
Effective July 1, 2005, the HMO entered into a contract with CMS (the "CMS
Contract") to begin offering Medicare Advantage plans to Medicare beneficiaries
in six Florida counties - Lee, Charlotte, Sarasota, Martin, St. Lucie and
Okeechobee. Beginning January 1, 2007, the HMO began to provide services in
Polk, Glades, Manatee, Marion, Lake and Sumter counties. In July 2007, the HMO
was approved to operate in Collier County beginning January 1, 2008. The HMO has
been marketing its "AdvantageCare" branded plan since July 2005.
The HMO is required to maintain satisfactory minimum net worth in accordance
with requirements established by the Florida State Office of Insurance
Regulation. The HMO is restricted from making dividend payments without
appropriate regulatory notifications and approvals or to the extent such
dividends would put us out of compliance with statutory capital requirements.
We continue to evaluate expanding our HMO business into other counties within
Florida. However, we do not intend to provide HMO services in the geographic
markets covered by the Humana Agreements. We view our HMO business as an
extension of our existing core competencies.
The HMO's revenue is generated by premiums consisting of monthly payments per
customer that are established by the CMS Contract. The monthly premium for a
customer varies by, among other things county, age and health status of the
customer.
While the HMO's business has continued to grow, such growth has required and is
expected to continue to require a considerable amount of capital. We believe
that in 2008, the HMO's business will continue to generate a loss before
allocated overhead and income taxes. The HMO's actual cash needs and losses for
2008 are expected to be strongly influenced by, among other things, the HMO's
customer base, operating costs and the Medical Expense Ratio as well as the cost
and effectiveness of various marketing programs we may undertake. In July 2007,
we restructured our HMO operations by closing two office locations and
terminating eight employees to better match the current size of the HMO. During
the first nine months of 2007, we transferred $14.5 million to the HMO to fund
the operations and growth of the HMO. See - "LIQUIDITY AND CAPITAL RESOURCES"
section contained in this Form 10-Q.
To successfully operate the HMO, we believe we will have to continue our
development of the following capabilities, among others: sales and marketing,
medical management, network management and regulatory compliance. No assurances
can be given that we will be successful in operating this segment of our
business despite our allocation of a substantial amount of resources for this
purpose. If the HMO does not develop as anticipated or planned, we would likely
explore strategic alternatives for the business and/or devote additional
managerial and/or capital resources to the HMO, which could limit our ability to
manage and/or grow the PSN. There can be no assurances that, if for any reason,
we elect to discontinue the HMO business and/or seek to sell such business, we
will be able to fully recoup our expenditures to date with respect to the HMO
business.
CRITICAL ACCOUNTING POLICIES
Critical Accounting Policies
The preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the amounts reported in the accompanying
financial statements. Actual results may ultimately differ materially from those
estimates. We believe that the following discussion addresses our most critical
accounting policies, including those that are perceived to be the most important
to the portrayal of our financial condition and results of operations and that
require complex and/or subjective judgments by management.
16
We believe that our most critical accounting policies include "Use of Estimates,
Revenue, Expense and Receivables" and "Use of Estimates, Deferred Tax Asset."
Use of Estimates, Revenue, Expense and Receivables.
Our revenue is primarily derived from risk-based health insurance arrangements
in which the premium is fixed and paid to us on a monthly basis. We assume the
economic risk of funding our customers' health care services and related
administrative costs. Premium revenue is recognized in the period in which
eligible individuals are entitled to receive health care services. Because we
have the obligation to fund medical expenses, we recognize gross revenue and
medical expenses for these contracts in our consolidated financial statements.
We record health care premium payments we receive in advance of the service
period as unearned premiums.
CMS periodically retroactively adjusts the premiums paid to us based on the
updated health status of participants. The factors considered by CMS include
changes in demographic factors, risk adjustment scores, customer information and
adjustments mandated by the risk sharing requirements for prescription drug
benefits under Part D of the Medicare program. In addition, CMS retroactively
adjusts the number of customers enrolled in our HMO or PSN as a result of
enrollment changes not yet processed, or not yet reported by Humana or CMS.
These retroactive adjustments could, in the near term, materially impact the
revenue that has been recorded by us for both our HMO and PSN. We record any
adjustments to this revenue at the time the information necessary to make the
determination of the adjustment is available from Humana or CMS and the
collectibility of the amount is reasonably assured.
Medical expenses for both the PSN and HMO are recognized in the period in which
services are provided and include an estimate of our obligations for medical
services that have been provided to our customers but for which we have either
not yet received or processed claims, and for liabilities for physician,
hospital and other medical expense disputes. We estimate liabilities for
physician, hospital and other medical expense disputes based upon an analysis of
potential outcomes, assuming a combination of litigation and settlement
strategies. We develop our estimated medical claims payable by using an
actuarial process that is consistently applied. The actuarial process and models
develop a range of estimated medical claims payable and we record to the amount
in the range that is our best estimate of the ultimate liability.
Each period, we re-examine previously recorded estimated medical claims payable
based on actual claim submissions and other changes in facts and circumstances.
As the estimate of medical claims payable recorded in prior periods becomes more
exact, we adjust the amount of our estimates, and include the changes in medical
expense in the period in which the change is identified. In each reporting
period, our operating results include the effects of more completely developed
medical expense payable estimates associated with previously reported periods.
While we believe our estimated medical expenses payable are adequate to cover
future claims payments required, such estimates are based on our claims
experience to date and various management assumptions. Therefore, the actual
liability could differ materially from the amounts recorded.
Use of Estimates, Deferred Tax Assets.
We have recorded net deferred tax assets of approximately $5.5 million at
September 30, 2007. Realization of the deferred tax assets is dependent on
generating sufficient taxable income in the future. In order to fully utilize
the deferred tax assets, we will have to generate taxable income of
approximately $14.6 million. We believe that our current operations will
generate sufficient income to fully utilize this asset. The amount of the
deferred tax asset considered realizable could change materially in the near
term if our estimates of future taxable income are modified.
In the event we determine that we cannot, on a more-likely-than-not basis,
realize all or part of our deferred tax assets in the future, an adjustment to
establish a deferred tax asset valuation allowance would be charged to income in
the period such determination is made.
COMPARISON OF RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED SEPTEMBER 30,
2007 AND SEPTEMBER 30, 2006
Summary
During the three months ended September 30, 2007 and 2006, we operated in two
financial reporting segments, the PSN business and the HMO business.
17
For the three months ended September 30, 2007, we realized consolidated revenue
of $69.6 million compared to $60.8 million of revenue realized for the three
months ended September 30, 2006, an increase of approximately $8.8 million or
14.4%.
Of this increase, approximately $3.3 million related to the PSN. The increase is
due primarily to a premium increase from CMS of approximately 4% and an increase
in the average medicare risk score of customers, partially offset by a decline
in membership.
As more fully described below, the PSN's third quarter revenue in 2007 was
impacted by changes in the estimated settlements related to Medicare's drug
program for 2007 and 2006. These changes had the effect of reducing the PSN's
2007 third quarter revenue for out of period revenue by approximately $1.0
million. The impact reduced net income for the third quarter by approximately
$624,000 and reduced earnings per share for the quarter by $.01 per share.
Conversely, in the third quarter of 2006, the PSN recorded a benefit of $763,000
for Medicare risk score adjustments related to prior years, which increased net
income by approximately $475,000 and increased earnings per share for the three
months ended September 30, 2006 by $.01
The remaining $5.5 million of the increase in revenue is related to the HMO and
is principally the result of the increase in customer months between the third
quarter of 2007 and the third quarter of 2006, an increase in the average risk
score of its customers, and a premium increase from CMS. In the third quarter of
2006, the HMO recorded revenue from a retroactive risk share adjustment for the
first nine months of 2006 of approximately $534,000. The MRA adjustment for 2007
was recorded in the second quarter of 2007.
Customer months, the aggregate number of customers to whom the PSN provided
services for each month during the applicable period, for the PSN decreased to
approximately 74,400 in the third quarter of 2007 from approximately 76,600 in
the second quarter of 2007 and approximately 77,200 in the third quarter of
2006. At September 30, 2007, the PSN had approximately 24,600 customers as
compared to approximately 25,300 customers at June 30, 2007 and approximately
25,700 customers at September 30, 2006. Of the 1,100 reduction in our PSN
customer base, approximately 450 was related to the closing of an unprofitable
PSN-owned physician practice in South Florida with the balance being related to
deaths, people leaving the covered areas, transfers to another physician
practice or other insurance selections.
HMO customer months for the 2007 third quarter were 16,500. This compares to
15,200 HMO customer months for the 2007 second quarter and 10,300 HMO customer
months for the 2006 third quarter. At September 30, 2007, the HMO customer base
had increased to approximately 6,000 customers as compared to approximately
5,100 customers at the end of the second quarter of 2007 and approximately 3,500
customers at the end of the third quarter of 2006. The growth in HMO customers
from the end of the third quarter of 2006 to the end of the third quarter of
2007, resulted primarily from the enrollment of new customers during the 2007
open enrollment period and the enrollment realized during the special election
period afforded customers of a Medicare Advantage plan that had its contract
terminated by CMS in July 2007.
Consolidated total medical expense for the 2007 third quarter was $60.5 million,
an increase of $8.2 million over the 2006 third quarter. Our ratio of medical
expense to revenue (the "Medical Expense Ratio" or "MER") increased to 86.9% in
the 2007 third quarter compared to 85.9% in the 2006 third quarter. The increase
is a result of the growth of the HMO and its increased impact on our
consolidated results. As discussed below, the impact of retroactive premium
adjustments and prior period claims development also impacted the MER for the
2007 and 2006 third quarters.
Included in consolidated operating expenses in the 2007 third quarter was a
restructuring charge of approximately $583,000 and marketing costs of
approximately $500,000 associated with a special election period commencing in
late July 2007 and ending on September 30, 2007 allowing the customers of a
Medicare Advantage plan that had its contract terminated by CMS in July 2007 to
enroll in a new Medicare Advantage Plan. We did not incur similar expenses in
the 2006 third quarter.
Income before income tax expense for the 2007 third quarter was $2.4 million
compared to $4.1 million in the 2006 third quarter. The decrease in the income
before income tax expense between the quarters is a result of the items
discussed above. Net income for the 2007 third quarter was $1.6 million compared
to $2.5 million for the 2006 third quarter.
18
Net earnings per common share, basic and diluted was $0.03 for the 2007 third
quarter and $.05 for the 2006 third quarter.
The PSN reported a segment gain before income taxes and allocated overhead of
$8.0 million for the 2007 third quarter, as compared to a gain of $7.7 million
in the 2006 third quarter, an increase of $386,000 or 5.0%. The primary reason
for the increase in the PSN income before income taxes and allocated overhead
between the 2007 and 2006 third quarters is the improved gross margin primarily
offset by the impact of the Part D settlement adjustment discussed above. The
HMO segment incurred a net loss before income taxes and allocated overhead of
$3.1 million for the 2007 third quarter compared to a net loss before income
taxes and allocated overhead of $2.0 million in the 2006 third quarter. This
increase is primarily a result of the increasing general and administrative
costs associated with the growth in membership and the additional sales and
marketing costs and restructuring costs discussed above. Allocated corporate
overhead increased to $2.5 million from $1.5 million in the 2007 and 2006 third
quarters, respectively. This increase was primarily a result of increased
professional fees, increases in bonus expense in the 2007 third quarter (see
Payroll, Payroll Taxes and Benefits below) and additional payroll costs
associated with supporting the growing HMO.
Customer Information
The table set forth below provides (i) the total number of customers to whom we
were providing healthcare services through the PSN and HMO as of September 30,
2007 and September 30, 2006 and (ii) the aggregate customer months of the PSN
and the HMO during the third quarter of 2007 and 2006.
September 30, 2007 September 30, 2006
------------------------- ----------------------------
Customers Customers Customers Customer Percentage Change in
at End of Months For at End of Months for Customer Months Between
Period Quarter Period Quarter Quarters
----------- ------------ ------------ -------------- ------------------------
PSN 24,600 74,400 25,700 77,200 -3.6%
HMO 6,000 16,500 3,500 10,300 60.2%
----------- ------------ ------------ --------------
Total 30,600 90,900 29,200 87,500
=========== ============ ============ ==============
Revenue
The following table provides a breakdown of our sources of revenue by segment
for the 2007 third quarter and the 2006 third quarter:
Three Months Ended September 30 $ %
Increase
2007 2006 (Decrease) Change
------------- ------------- ------------- ------
PSN revenue from Humana $ 55,346,000 $ 51,962,000 $ 3,384,000 $ 6.5%
PSN fee-for-service revenue 270,000 354,000 (84,000) -23.7%
------------- ------------- ------------- ------
Total PSN revenue 55,616,000 52,316,000 3,300,000 6.3%
------------- ------------- ------------- ------
Percentage of total revenue 79.9% 86.0%
HMO revenue 14,006,000 8,522,000 5,484,000 64.4%
Percentage of total revenue 20.1% 14.0%
------------- ------------- ------------- ------
Total revenue $ 69,622,000 $ 60,838,000 $ 8,784,000 14.4%
============= ============= ============= ======
The PSN's most significant source of revenue during both the 2007 and 2006 third
quarters was the premium revenue generated pursuant to the Humana Agreements
(the "Humana Related Revenue"). The Humana Related Revenue increased from $52.0
million in the 2006 third quarter to $55.3 million in the 2007 third quarter, an
increase of approximately 6.5%.
During the third quarter of 2007, based on drug costs incurred during the year,
utilization patterns and changes in actuarial assumptions underlying future drug
cost projections, we recorded a liability for premium payments in excess of drug
costs for the PSN of approximately $3.0 million representing the amount of
premium payments we estimate we will be required to refund to CMS under the
Medicare Part D program for prescription drug costs incurred during the first
nine months of 2007. Of this $3 million, approximately $2.0 million relates to
premiums received in the first half of 2007. Accordingly, we reduced revenue in
the third quarter and accrued a liability for the $3.0 million at September 30,
2007. We anticipate that this change in our estimated final Part D settlement
will also reduce the PSN's revenue in the fourth quarter of 2007 by an
additional $1.0 million. CMS will make its ultimate determination regarding 2007
Medicare Part D payments in 2008 (the "Final Part D Settlement").
19
As of December 31, 2006, the PSN had recorded an estimated Part D settlement for
2006. Based upon the final determination by CMS in October 2007 of Medicare Part
D costs incurred by the PSN in 2006, we recorded additional revenue in the third
quarter of 2007 of approximately $1.0 million, representing the amount by which
our 2006 year-end estimate exceeded the final amount.
The Medicare Part D adjustments described above had the net effect of decreasing
the PSN's revenue for the third quarter of 2007 by approximately $1.0 million,
reducing the per customer per month premium for the third quarter of 2007 by
approximately $13.00 and increasing the PSN's MER in the 2007 third quarter by
1.5%.
In the third quarter of 2006, the PSN recorded additional revenue of $763,000
for Medicare risk score adjustments related to prior years. This adjustment
increased the average per customer per month premium in the third quarter of
2006 by approximately $10 and had the effect of lowering the PSN's MER in the
third quarter of 2006 by 1.3%.
The PSN's average per customer per month premium in the 2007 third quarter was
approximately $748, an increase of approximately $71 or 10.5% per customer per
month over the 2006 third quarter per customer per month premium of $677.
Excluding the items described in the preceding paragraphs, the net change in the
revenue per customer per month between the 2007 third quarter and the 2006 third
quarter was $94. The increase in the PSN's per customer per month revenue is due
to a premium increase from CMS of approximately 4% and an increase in the
average Medicare risk score of our customers.
Fee-for-service revenue represents amounts earned from medical services provided
to non-Humana customers by the PSN's owned physician practices.
Revenue for the HMO increased by $5.5 million or 64.4%, from $8.5 million to
$14.0 million. The increase in revenue is primarily attributable to the 60%
increase in the HMO's customer months between the 2007 and 2006 third quarters.
Revenue per customer per month for the HMO increased from $828 for the 2006
third quarter to $851 for the 2007 third quarter. This increase is primarily due
to a combination of the 2007 rate increase in the premium payments from CMS and
an increase in the average Medicare risk scores of our customers.
Included in the HMO's revenue for the third quarter of 2006 was a risk score
adjustment for the first six months of 2006 of $534,000. This increased the
revenue per customer per month by approximately $52 and lowered the MER for the
2006 third quarter by 6.6%. The risk adjustment for 2007 was recorded in the
second quarter of 2007.
Medical Expense
Total medical expense represents the estimated total cost of providing patient
care and is comprised of two components, medical claims expense and medical
center costs. Medical claims expense for both the PSN and HMO are recognized in
the period in which services are provided and include an estimate of our
obligations for medical services that have been provided to our customers but
for which we have either not yet received or processed claims, and for
liabilities for physician, hospital and other medical expense disputes. Medical
claims expense includes such costs as inpatient and outpatient services,
pharmacy benefits and physician services by providers other than the physician
practices owned by the PSN (collectively "Non-Affiliated Providers"). Medical
center costs represent the operating costs of the physician practices owned by
the PSN.
We develop our estimated medical expenses payable by using an actuarial process
that is consistently applied. The actuarial process and models develop a range
of estimated medical expenses payable and we record to the amount in the range
that is our best estimate of the ultimate liability. Each period, we re-examine
previously established medical claims payable estimates based on actual claim
submissions and other changes in facts and circumstances. As medical expenses
recorded in prior periods becomes more exact, we adjust the amount of the
estimate, and include the change in medical expense in the period in which the
change is identified. In each reporting period, our operating results include
the effects of more completely developed medical expense payable estimates
associated with previously reported periods. While we believe our estimated
medical expenses payable is adequate to cover future claims payments required,
such estimates are based on our claims experience to date and various management
assumptions. Therefore, the actual liability could differ materially from the
amount recorded.
20
Total Medical Expense
Medical costs and the Medical Expense Ratio for the three month period ending
September 30 are as follows:
2007 2006
------------------------------------------- ------------------------------------------
HMO PSN Consolidated HMO PSN Consolidated
---------------------------------------------------------------------------------------
Estimated medical expense for the
quarter, excluding prior period claims
development $ 13,040,000 $ 47,907,000 $ 61,415,000 $ 7,845,000 $ 45,104,000 $ 54,197,000
(Favorable) unfavorable prior period
medical claims development in current
period based on actual claims submitted $ 863,000 $ (1,305,000) $ (910,000) $ 613,000 $ (1,307,000) (1,942,000)
------------ ------------ ------------ ------------ ------------ ------------
Total reported medical expense for
quarter $ 13,903,000 $ 46,602,000 $ 60,505,000 $ 8,458,000 $ 43,797,000 $ 52,255,000
============ ============ ============ ============ ============ ============
Reported Medical Expense Ratio for
quarter 99.3% 83.8% 86.9% 99.2% 83.7% 85.9%
============ ============ ============ ============ ============ ============
Medical Expense Ratio for the quarter,
excluding the impact of retroactive
premium adjustments and prior period
medical claims development 93.1% 85.2% 86.8% 96.5% 84.9% 86.4%
============ ============ ============ ============ ============ ============
In the table above, favorable adjustments to amounts we recorded in prior
periods for estimated claims payable appear in parentheses while unfavorable
adjustments do not appear in parentheses. Favorable adjustments reduce total
medical expense for the respective applicable period and unfavorable claims
development increases total medical expense for the applicable period.
Total consolidated medical expense was $60.5 million and $52.3 million for the
2007 and 2006 third quarters, respectively. Approximately $57.7 million or 95.4%
of our total medical expense in the 2007 third quarter and $49.7 million or
95.1% of total medical expense in the 2006 third quarter are attributable to
medical claims.
Our Medical Expense Ratio increased from 85.9% in the 2006 third quarter to
86.9% in the 2007 third quarter primarily as a result of the increased impact of
the HMO on our consolidated medical costs and the HMO's higher MER.
The reported Medical Expense Ratio is impacted by both revenue and expense.
Retroactive adjustments of prior period's premiums that are recorded in the
current period impact the MER of that period. If the retroactive adjustment is
positive then the impact reduces the recorded MER. Conversely, if the
retroactive adjustment reduces revenue of the period, then the MER for the
period is higher. These retroactive adjustments include, among other things, the
mid-year and annual MRA adjustments and settlement of Part D program premiums.
In addition, actual medical claims expense usually develops differently than
estimated during the period. Therefore, the estimated actual MER shown in the
table above will likely change as additional claim development occurs. Favorable
claims development is a result of actual medical claim cost for prior periods
developing lower than the original estimated cost which reduces the reported
medical expense and the MER for the current quarter. Unfavorable claims
development is a result of actual medical claim cost for prior periods exceeding
the original estimated cost which increases total reported medical expense and
the MER for the current quarter. We believe the Medical Expense Ratio excluding
the impact of retroactive premium adjustments and prior period medical claims
development is useful in understanding the operating performance for the period
since this measure excludes the impact of retroactive premium adjustments on
revenue and the impact of prior period claim development on medical expense.
21
A change of approximately $140,000 in the third quarter of 2007 in either
revenue or medical claims expense impacts the MER for the HMO by 1%. In the
third quarter of 2006, a change in either revenue or medical claims expense of
approximately $80,000 impacts the HMO's MER by 1%. For the PSN, a change in
either revenue or medical claims expense of approximately $525,000 impacts the
PSN's MER by 1% in the third quarters of 2007 and 2006.
The Humana Agreements provide that the PSN is financially responsible for all
medical services provided to the Humana Participating Customers. The PSN's total
medical expense in the 2007 third quarter was $46.6 million compared to $43.8
million in the 2006 third quarter, an increase of approximately $2.8 million.
Approximately $2.8 million of our total medical expense in the 2007 third
quarter related to physician practices we own as compared to $2.5 million in the
2006 third quarter.
The PSN's Medical Expense Ratio in the 2007 third quarter was 83.8% as compared
to 83.7% in the 2006 third quarter. The PSN'S MER was impacted by the prior
period medical claim development reflected in the above chart and the revenue
items described in the Revenue section above. Giving consideration to these
items the estimated MER excluding the impact of retroactive premium adjustments
and prior period medical claims development for the third quarter of 2007 was
85.2% as compared to 84.9% for the third quarter of 2006. This increase is
primarily a result of increased rates paid to hospitals and an increase in the
intensity of the health services required by our customers as indicated by the
increase in the risk scores of these customers.
At September 30, 2007, we determined that the range for estimated medical claims
payable for the PSN was between $13.4 million and $14.5 million and we recorded
a liability of $13.9 million. Based on historical results, we believe that the
mid-point of the range continues to be the best estimate within the range of the
PSN's ultimate liability.
Total medical expense for the HMO was $13.9 million in the 2007 third quarter
compared to $8.5 million in the 2006 third quarter. The increase in the 2007
third quarter of 63.4% is due primarily to the 60% increase in the number of HMO
customer months between the 2007 and 2006 third quarters.
The HMO's Medical Expense Ratio in the 2007 third quarter was 99.3% as compared
to 99.2% in the 2006 third quarter. The HMO's MER was impacted by the prior
period medical claim development reflected in the above chart and the revenue
item described in the Revenue section above. The Medical Expense Ratio,
excluding the retroactive premium adjustments and medical claims development of
prior periods, for the 2007 quarter was 93.1% as compared to 96.5% in 2006. This
improvement is a result of decreasing medical costs and lower inpatient days.
At September 30, 2007, we determined that the range for estimated medical claims
payable for the HMO was between $6.4 million and $7.4 million and we recorded a
liability of $6.4 million. Based on historical results, we believe that the low
end of the range continues to be the best estimate of the HMO's ultimate
liability.
Operating Expenses
Three Months Ended September 30 Increase %
2007 2006 (Decrease) Change
------------- ------------- ------------- -----------
Payroll, payroll taxes and benefits $ 3,357,000 $ 2,536,000 $ 821,000 32.4%
Percentage of total revenue 4.8% 4.2%
Marketing and advertising 578,000 203,000 375,000 184.7%
Percentage of total revenue 0.8% 0.3%
Restructuring expense 583,000 -- 583,000 --
Percentage of total revenue 0.8% 0.0%
General and administrative 2,589,000 2,080,000 509,000 24.5%
Percentage of total revenue 3.7% 3.4%
------------- ------------- -------------
Total operating expenses $ 7,107,000 $ 4,819,000 $ 2,288,000 47.5%
============= ============= =============
Payroll, Payroll Taxes and Benefits
22
Payroll, payroll taxes and benefits include salaries, sales commissions and
related costs for our executive, administrative and sales staff. For the 2007
third quarter, payroll, payroll taxes and benefits were $3.4 million, compared
to $2.5 million for the 2006 third quarter, an increase of approximately
$821,000. Payroll, payroll taxes and benefit costs associated with the HMO
segment and corporate accounted for substantially all of this increase.
Sales commissions paid by the HMO, related to the enrollment of the customers of
the Medicare Advantage plan that had its contract terminated by CMS in July
2007, accounted for $100,000 of this increase.
As the HMO's customer base has grown, we have increased our HMO staff to meet
the operational needs of the HMO's growing customer base. The increase in
full-time employees resulted in payroll, payroll taxes and benefits attributable
to the HMO increasing to $1.3 million in the 2007 third quarter as compared to
$1.1 million in the 2006 third quarter, a 27.1% increase.
Increases in bonus expense in the 2007 third quarter accounted for $550,000 of
the increase as we adjusted the amount accrued at September 30, 2007 to give
effect to the final 2007 bonus plan.
Marketing and Advertising
Marketing and advertising expense includes advertising expenses and brokerage
commissions paid to independent sales agents. For the 2007 third quarter,
marketing and advertising expense was $578,000 as compared to $203,000 for the
2006 third quarter, an increase of 184.7%. The primary reason for this increase
was the marketing costs and commissions associated with the special enrollment
period afforded customers of a Medicare Advantage plan that had its contract
terminated by CMS in July 2007.
Restructuring Expenses
As part of our continuing efforts to enhance our profitability, in July 2007, we
implemented a restructuring plan designed to reduce costs and improve operating
efficiencies. The restructuring plan, completed by the end of August 2007,
resulted in the closure of two of the HMO's office locations, one PSN medical
practice (the "PSN Practice"), and a workforce reduction involving 16 employees.
In connection with this plan, we recorded approximately $583,000 of
restructuring costs during the third quarter of 2007 including approximately
$147,000 for severance payments, approximately $364,000 for continuing lease
obligations on closed locations and approximately $72,000 for the write-off of
certain leasehold improvements and equipment. During the third quarter of 2007,
we made cash payments related to the restructuring of $191,000. The severance
payments and continuing lease obligations will result in additional future cash
expenditures. We believe that the restructuring will enable us to reduce our
related operating expenses by approximately $1.2 million per annum, with no or
limited impact on the HMO's and PSN's ability to serve their existing customers.
At the time of its closure on July 31, 2007, the PSN Practice served
approximately 450 customers in South Florida, all of which were moved to other
providers outside of the PSN. Prior to its closing on July 31, the PSN practice
generated approximately $2.6 million of revenue in 2007 and had a negative gross
margin. Of the $583,000 restructuring charge, approximately $400,000 relates to
the HMO with the balance of $183,000 associated with the PSN.
General and Administrative
General and administrative expenses for the 2007 third quarter totaled $2.6
million, an increase of $509,000, or 24.5% over the 2006 third quarter.
Approximately $242,000 of the increase in general and administrative costs is
attributable to the growth of the HMO. The HMO incurred increased costs of
$224,000 relating to claims processing as the number of HMO customers increased.
Corporate general and administrative costs for the 2007 third quarter were
approximately $1.2 million as compared to $828,000 for the 2006 third quarter,
an increase of 47.4%. Approximately $262,000 of the increase relates to an
increase in professional service costs with another $72,000 resulting from
increased director fees.
Other Income (Expense)
We realized other income of $373,000 in the 2007 third quarter as compared to
$306,000 in the 2006 third quarter. Investment income in the 2007 third quarter
increased by $71,000 over the 2006 third quarter as we had more cash to invest
and interest rates increased as compared to the 2006 third quarter. Cash is
invested in highly liquid securities, primarily certificates of deposits with
short term maturities and money market funds. We expect to continue to invest
our excess cash in this manner for the remainder of 2007.
23
Income taxes
Our effective tax rate was 33% in the 2007 third quarter and 37.8% in the 2006
third quarter. The decrease in the effective income tax rate in the 2007 third
quarter is a result of our recognition of an approximate $120,000 tax benefit
upon the expiration of the statute of limitations for the tax period to which
the benefit relates.
COMPARISON OF RESULTS OF OPERATIONS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007
AND SEPTEMBER 30, 2006
Summary
During the nine months ended September 30, 2007 and 2006, we operated in two
financial reporting segments, the PSN business and the HMO business.
For the nine months ended September 30, 2007, we realized consolidated revenue
of $207.7 million compared to $172.5 million of revenue realized for the nine
months ended September 30, 2006, an increase of approximately $35.2 million or
20.4%.
Of this increase, approximately $16.8 million is related to the PSN. This
increase in revenue is due to an increase of approximately 4% in the premium
payment from CMS in 2007 and an increase in the average Medicare risk score of
the PSN's customers, partially offset by the decline in the customer base.
As more fully described below, the PSN's 2007 nine month revenue was impacted by
a change in the estimated settlement related to Medicare's drug program for
2006. This increase in revenue had the effect of increasing the PSN's 2007 nine
month revenue by approximately $1 million. This item increased net income for
the nine month period ended September 30, 2007 by approximately $624,000 and
increased earnings per share by $.01. In the third quarter of 2006, the PSN
recorded a benefit of $763,000 for Medicare risk score adjustments related to
prior years, which increased net income by $475,000 and increased earnings per
share for the nine months ended September 30, 2006 by $.01.
Approximately $18.4 million of the increase is related to the HMO and is
principally the result of the increase in customer months between the first nine
months of 2007 and the first nine months of 2006. In July 2007, the HMO received
the final 2006 Medicare risk score adjustment from CMS of $575,000. This amount
was $340,000 higher than our recorded estimate at December 31, 2006 and March
31, 2007 of $235,000. The $340,000 was recorded in revenue in the second quarter
of 2007.
Customer months for the PSN for the nine months ended September 30, 2007
decreased to approximately 227,700 in the third quarter of 2007 from
approximately 232,000 for the same period in 2006, a decline of 2.0%. The drop
in our customer base is a result of the closing of an unprofitable center in
South Florida with approximately 450 customers on July 31, 2007 with the balance
being related to deaths, people leaving the covered areas, transfers to another
physician practice or other insurance selections.
Customer months for the HMO for the nine months ended September 30, 2007 were
45,200 as compared to 24,700 for the same period in 2006, an increase of 83%.
The increase is a result of our successful marketing efforts during 2007.
Total consolidated medical expense for the first nine months of 2007 was $181.8
million, an increase of $29.1 million over the total medical expense of $152.7
million incurred in the first nine months of 2006. Our Medical Expense Ratio
decreased to 87.5% for the first nine months of 2007 compared to 88.6% in 2006.
This increase is primarily a result of the growth of the HMO and its increasing
impact on our consolidated results. As discussed below, the impact of
retroactive premium adjustments and prior period claims development also
impacted the MER for the 2007 and 2006 third quarters.
24
Included in consolidated operating expenses for the first nine months of 2007
are:
o Severance benefits payable pursuant to a Separation Agreement with
our former President and Chief Operating Officer of $500,000;
o A restructuring charge of approximately $583,000; and
o Additional marketing costs of $500,000 associated with the special
election period afforded the customers of a Medicare Advantage plan
that had its contract terminated by CMS in July 2007. The special
enrollment period allowed customers of the terminated plan to elect
to join another plan during the period from late July 2007 to
September 30, 2007.
These items reduced net income by approximately $1,000,000 and reduced earnings
per share by $.02.
Consolidated income before income taxes for the first nine months of 2007 was
$5.4 million compared to $5.1 million for the first nine months of 2006,
primarily for the reasons discussed above. Net income for the first nine months
of 2007 was $3.4 million compared to $3.2 million for the first nine months of
2006. Our results of operations for the first nine months of 2007 and 2006 were
negatively impacted by losses related to the operations of our Medicare
Advantage HMO.
Net earnings per common share, basic and diluted were $0.07 and $0.06,
respectively for the first nine months of 2007 and $0.06 for the first nine
months of 2006.
The PSN reported a segment gain before income taxes and allocated overhead of
$21.1 million for the first nine months of 2007, as compared to $16.2 million
for the first nine months of 2006, an increase of $4.9 million or 30.9%. This
increase is primarily a result of the lower Medical Expense Ration for the PSN
and thus, increased gross margin. The HMO segment incurred a net loss before
income taxes and allocated overhead of $8.7 million for the first nine months of
2007, compared to a net loss before income taxes and allocated overhead of $6.2
million in the first nine months of 2006. This decrease is a result of an
increase in gross margin of approximately $1 million being offset by salaries,
sales and marketing costs and general and administrative costs associated with
the growth of members in the HMO. Allocated overhead was $7.1 million and $4.8
million for the first nine months of 2007 and 2006, respectively. This increase
was a result of severance benefits of $500,000, an increase in bonus costs of
approximately $550,000 and an increase in general & administrative costs of
approximately $1.2 million as discussed in more detail in that section below.
Customer Information
The table set forth below provides (i) the total number of customers to whom we
were providing healthcare services through the PSN and HMO as of September 30,
2007 and September 30, 2006 and (ii) the aggregate customer months of the PSN
and the HMO during the first nine months of 2007 and 2006.
September 30, 2007 September 30, 2006
----------------------- ------------------------
Members at Member Members at Member Percentage Change in
End of End of Customer Months Between
Period Months YTD Period Months YTD Periods
----------- ---------- ----------- ---------- -----------------------
PSN 24,600 227,700 25,700 232,300 -2.0%
HMO 6,000 45,200 3,500 24,700 83.0%
----------- ---------- ----------- ----------
Total 30,600 272,900 29,200 257,000
=========== ========== =========== ==========
Revenue
The following table provides a breakdown of our sources of revenue by segment
for year to date 2007 and 2006:
25
Nine Months Ended September 30 $
Increase %
2007 2006 (Decrease) Change
------------- ------------- ------------- -----------
PSN revenue from Humana $ 168,407,000 $ 151,570,000 $ 16,837,000 11.1%
PSN fee-for-service revenue 964,000 1,059,000 (95,000) -9.0%
------------- ------------- -------------
Total PSN revenue 169,371,000 152,629,000 16,742,000 11.0%
------------- ------------- -------------
Percentage of total revenue 81.6% 88.5%
HMO revenue 38,289,000 19,857,000 18,432,000 92.8%
Percentage of total revenue 18.4% 11.5%
------------- ------------- -------------
Total revenue $ 207,660,000 $ 172,486,000 $ 35,174,000 20.4%
============= ============= =============
The PSN's most significant source of revenue during both the first nine months
of 2007 and 2006 was the premium revenue generated pursuant to the Humana
Agreements (the "Humana Related Revenue"). The Humana Related Revenue increased
from $151.6 million for the first nine months of 2006 to $168.4 million for the
first nine months of 2007, an increase of approximately 11.1%.
As of December 31, 2006, the PSN had recorded an estimated Part D settlement for
2006. In October 2007, CMS determined the final settlement liability for 2006
Part D costs of the PSN. The ultimate liability was approximately $1.0 million
lower than we had estimated at December 31, 2006. This amount has been recorded
as additional revenue for the nine month period ended September 30, 2007 and
decreased the MER for the first nine months of 2007 by .5%. In the first nine
months of 2006, the PSN recorded additional revenue of $763,000 for Medicare
risk score adjustments related to prior years. This decreased the MER for the
PSN for the nine month period ended September 30, 2006 by .4%.
The PSN's average per customer per month premium in the first nine months of
2007 was approximately $744, an increase of approximately $87 or 13.2% over the
average per customer per month premium for the first nine months of 2006 of
$657. This increase in the average per customer per month premium is due to an
increase of approximately 4% in the premium payment from CMS in 2007 and an
increase in the average Medicare risk score of the PSN's customers.
Fee-for-service revenue represents amounts earned from medical services provided
to non-Humana customers in the PSN's owned physician practices.
The HMO's revenue was $38.3 million for the first nine months of 2007 as
compared to $19.9 million for the first nine months of 2006, an increase of
$18.4 million or 92.8%. The increase in revenue is primarily attributable to the
increase in customer months between the first nine months of 2006 and the first
nine months of 2007 and the 2007 rate increase from CMS. The HMO's average per
customer per month premium for the HMO increased to $847 in the first nine
months of 2007 from $805 in the first nine months of 2006, an increase of 5.2%.
This increase is primarily a result of the 2007 rate increase from CMS.
In July 2007, the HMO received $575,000 as the final Medicare risk score
adjustment from CMS for 2006. This increase in the premiums is $340,000 higher
than our recorded estimate of $235,000. The $340,000 has been recorded as
additional revenue for the nine month period ended September 30, 2007. This
additional revenue lowered the HMO's MER for the nine month period ended
September 30, 2007 by .9%.
Medical Expense
Total Medical Expense
Medical costs and the Medical Expense Ratio for the nine month period ended
September 30 are as follows:
26
2007 2006
--------------------------------------------- ---------------------------------------------
HMO PSN Consolidated HMO PSN Consolidated
------------- ------------- ------------- ------------- ------------- -------------
Estimated medical expense
for the period excluding prior
period claims development $ 36,939,000 $ 143,272,000 $ 180,211,000 $ 19,021,000 $ 134,333,000 $ 153,354,000
(Favorable) unfavorable prior
period medical claims development
in current period based on actual
claims submitted $ (599,000) $ 2,182,000 $ 1,583,000 $ (164,000) $ (446,000) $ (610,000)
------------- ------------- ------------- ------------- ------------- -------------
Total reported medical expense for
the period $ 36,340,000 $ 145,454,000 $ 181,794,000 $ 18,857,000 $ 133,887,000 $ 152,744,000
============= ============= ============= ============= ============= =============
Reported Medical Expense Ratio for
the period 94.9% 85.9% 87.5% 95.0% 87.7% 88.6%
============= ============= ============= ============= ============= =============
Medical Expense Ratio for the
quarter, excluding the impact of
retroactive premium adjustments and
prior period medical claims
development 97.3% 85.2% 87.5% 96.3% 87.2% 88.7%
============= ============= ============= ============= ============= =============
In the table above, favorable adjustments to amounts we recorded in prior
periods for estimated claims payable appear in parentheses while unfavorable
adjustments do not appear in parentheses. Favorable adjustments reduce total
medical expense for the respective applicable period and unfavorable claims
development increases total medical expense for the applicable period.
Total medical expense was $181.8 million and $152.7 million for the nine months
ended September 30, 2007 and 2006, respectively, an increase of $29.1 million or
19.0% Approximately $173.5 million or 95.5% of our total medical expense in the
2007 nine month period and $145.1 million or 95.0% of total medical expense in
the 2006 nine month period are attributable to medical claims expense.
Our Medical Expense Ratio decreased from 88.6% for the first nine months of 2006
to 87.5% for the same period in 2007.
The reported Medical Expense Ratio is impacted by both revenue and expense.
Retroactive adjustments of prior period's premiums that are recorded in the
current period impact the MER of that period. If the retroactive adjustment is
positive then the impact reduces the recorded MER. Conversely, if the
retroactive adjustment reduces revenue of the period, then the MER for the
period is higher. These retroactive adjustments include, among other things, the
mid-year and annual MRA adjustments and settlement of Part D program premiums.
In addition, actual medical claims expense usually develops differently than
estimated during the period. Therefore, the estimated actual MER shown in the
table above will likely change as additional claim development occurs. Favorable
claims development is a result of actual medical claim cost for prior periods
developing lower than the original estimated cost which reduces the reported
medical expense and the MER for the current period. Unfavorable claims
development is a result of actual medical claim cost for prior periods exceeding
the original estimated cost which increases total reported medical expense and
the MER for the period. We believe the Medical Expense Ratio excluding the
impact of retroactive premium adjustments and prior period medical claims
development is useful in understanding the operating performance for the period
since this measure excludes the impact of retroactive premium adjustments on
revenue and the impact of prior period claim development on medical expense.
A change of approximately $380,000 for the first nine months of 2007 in either
revenue or the medical claims expense impacts the MER of the HMO by 1%. In 2006,
a change in either revenue or medical claims expense of approximately $200,000
impacts the HMO's MER by 1%. For the PSN, a change in either revenue or medical
claims expense of approximately $1.7 million impacts the PSN's MER by 1% for the
nine month period ended September 30, 2007, and a change of approximately $1.5
million impacts the PSN's MER for the same period nine month period in 2006.
The Humana Agreements provide that the PSN is financially responsible for all
medical services provided to the Humana Participating Customers. The Medical
Expense Ratio for the PSN segment improved to 85.9% for the first nine months of
2007 as compared to 87.7% for the first nine months of 2006 and 88.4% for the
year ended December 31, 2006. The PSN'S MER was impacted by the prior period
medical claim development reflected in the above chart and the revenue items
described in the Revenue section above. Adjusting the MER for these prior period
items the MER for the PSN for the nine month period ended September 30, 2007 is
85.2% as compared to 87.2% for the same period in 2006.
27
The PSN's total medical expense for the first nine months of 2007 was $145.5
million, compared to $133.9 million in the first nine months of 2006, an
increase of approximately $11.6 million.
Approximately $8.3 million of our total medical expense in the first nine months
of 2007 related to physician practices owned by the PSN as compared to $7.6
million for the first nine months of 2006.
The Medical Expense Ratio for the HMO segment was 94.9% for the first nine
months of 2007 as compared to 95.0% for the first nine months of 2006 and 102.4%
for the year ended December 31, 2006. The HMO's MER was impacted by the prior
period medical claim development reflected in the above chart and the revenue
item described in the Revenue section above. Excluding these prior period items,
for the nine month period ended September 30, 2007, the HMO's MER was 97.3% as
compared to 96.3% for the same period in 2006. We experienced higher than
acceptable medical costs in the last quarter of 2006 and the first six months of
2007. During the second quarter of 2007, we renegotiated lower costs for certain
contracts and enhanced our medical management process. As a result, the HMO's
MER dropped to 93.1% in the third quarter of 2007.
Total medical expense for the HMO was $36.3 million for the first nine months of
2007 as compared to $18.9 million for the first nine months of 2006, an increase
of $17.5 million. This increase is substantially due to the increase in the
number of HMO customer months between the first nine months of 2007 and the
first nine months of 2006 and the premium rate increase for 2007 from CMS.
Operating Expenses
$
Nine Months Ended September 30 Increase %
2007 2006 (Decrease) Change
------------- ------------- ------------- ---------
Payroll, payroll taxes and benefits $ 10,101,000 $ 7,566,000 $ 2,535,000 33.5%
Percentage of total revenue 4.9% 4.4%
Marketing and advertising 2,609,000 2,217,000 392,000 17.7%
Percentage of total revenue 1.3% 1.3%
Restructuring expense 583,000 -- 583,000 --
Percentage of total revenue 3.0% 0.0%
General and administrative 8,242,000 5,555,000 2,687,000 48.4%
Percentage of total revenue 4.0% 3.2%
------------- ------------- -------------
Total operating expenses $ 21,535,000 $ 15,338,000 $ 6,197,000 40.4%
============= ============= =============
Payroll, Payroll Taxes and Benefits
Payroll, payroll taxes and benefits include salaries and related costs for our
executive, administrative and sales staff. For the first nine months of 2007,
payroll, payroll taxes and benefits were $10.1 million, compared to $7.6 million
in the first nine months of 2006, an increase of $2.5 million.
As the HMO's customer base had grown, we have increased our HMO staff. These
employees were added to meet the operational needs of the HMO's growing customer
base. The increase in full time employees resulted in payroll, payroll taxes and
benefits attributable to the HMO increasing to $4.3 million for the first nine
months of 2007 as compared to $2.9 million for the first nine months of 2006, an
increase of $1.4 million or 48.3%.
Included in corporate salary expense for the nine months ended September 30,
2007 is approximately $500,000 of severance benefits payable pursuant to the
Separation Agreement we entered into with our former President and Chief
Operating Officer in April 2007. Increases in the bonus expense for the first
nine months of 2007 accounted for $550,000 of the increase as we adjusted the
amount accrued at September 30, 2007 to give effect to the final 2007 bonus plan
that was approved by the Board of Directors during the third quarter of 2007.
28
Marketing and Advertising
Marketing and advertising expenses, which include advertising expenses and
brokerage commissions paid to independent sales agents, totaled $2.6 million for
the nine month period ended September 30, 2007, an increase of approximately
$392,000 over the first nine months of 2006. The primary reason for this
increase was marketing costs and commissions incurred in the third quarter of
2007 associated with the special enrollment period afforded customers of a
Medicare Advantage plan that had its contract terminated by CMS in July 2007.
Restructuring expenses
As part of our continuing efforts to enhance our profitability, in July 2007, we
implemented a restructuring plan designed to reduce costs and improve operating
efficiencies. The restructuring plan, completed by the end of August 2007,
resulted in the closure of two of the HMO's office locations, one PSN medical
practice (the "PSN Practice"), and a workforce reduction involving 16 employees.
In connection with this plan, we recorded approximately $583,000 of
restructuring costs during the third quarter of 2007 including approximately
$147,000 for severance payments, approximately $364,000 for continuing lease
obligations on closed locations and approximately $72,000 for the write-off of
certain leasehold improvements and equipment. During the third quarter of 2007,
we made cash payments related to the restructuring of $191,000. The severance
payments and continuing lease obligations will result in additional future cash
expenditures. We believe that the restructuring will enable us to reduce our
related operating expenses by approximately $1.2 million per annum, with no or
limited impact on the HMO's and PSN's ability to serve their existing customers.
At the time of its closure on July 31, 2007, the PSN Practice served
approximately 450 customers in South Florida, all of which were moved to other
providers outside of the PSN. Prior to its closing on July 31, the PSN practice
generated approximately $2.6 million of revenue in 2007 and had a negative gross
margin. Of the $583,000 restructuring charge, approximately $400,000 relates to
the HMO with the balance of $183,000 associated with the PSN.
General and Administrative
General and administrative expenses for the first nine months of 2007 totaled
$8.2 million, an increase of $2.7 million, or 48.4% as compared to the first
nine months of 2006.
The HMO incurred general and administrative costs of approximately $3.9 million
for the first nine months of 2007 as compared to approximately $2.4 million for
the first nine months of 2006, an increase of approximately $1.5 million or
63.0%. This increase is primarily attributable to additional infrastructure
required to service to the HMO's growing customer base, including $766,000
related to increased claims and customer services costs and increased
professional fees of approximately $450,000.
Corporate general and administrative costs for the first nine months of 2007
were $3.6 million as compared to $2.4 million for the first nine months of 2006,
an increase of 47.6% or $1.2 million. Approximately $700,000 of this increase
relates to an increase in professional service costs. In addition, depreciation
expense increased $130,000 and fees paid to our Board of Directors increased
$130,000.
Other Income (Expense)
We realized other income of $1.1 million for the first nine months of 2007 as
compared to $737,000 for the first nine months of 2006, an increase of $326,000.
Investment income for the first nine months of 2007 increased $352,000 over the
same period in 2006 as we had more cash to invest and rates have increased over
2006.
Income taxes
Our effective tax rate was 37.8% for the first nine months of 2007 and 37.9% for
the first nine months of 2006.
LIQUIDITY AND CAPITAL RESOURCES
Total cash and equivalents at September 30, 2007 were approximately $34.4
million as compared to approximately $23.1 million at December 31, 2006. Of our
$34.4 million of cash and equivalents at September 30, 2007, $15.7 million was
statutorily limited to use by the HMO.
29
We had working capital of approximately $24.6 million as of September 30, 2007
and $19.6 million at December 31, 2006.
Our total stockholders' equity was approximately $35.0 million and $30.9 million
at September 30, 2007 and December 31, 2006, respectively. Our increase in
stockholders' equity during the first nine months of 2007 is primarily
attributable to:
o Net income of $3.4 million;
o Stock based compensation of $548,000; and
o The exercise of stock options totaling $494,000, including the
related tax benefit of $245,000
The above increases were reduced by the impact of the adoption of FASB
Interpretation No. 48 which resulted in a charge to stockholder's equity of
$437,000.
During the nine months ended September 30, 2007, our cash and equivalents
increased $11.3 million over the balance at December 31, 2006. Operating
activities provided approximately $11.9 million in cash and equivalents, of
which net income accounted for approximately $3.4 million. Other large sources
of cash from operating activities were:
o an increase in amounts due to CMS of $1.8 million;
o an increase in estimated medical expenses payable of $1.6 million;
o a decrease in deferred income tax assets of $1.7 million;
o an increase in accrued payroll of $785,000;
o an increase in accrued expenses of $769,000;
o depreciation and amortization expense of $646,000; and
o stock based compensation expense of $548,000.
The increase in the due to CMS is primarily a result of the previously discussed
change in the PSN's estimated Part D liability for 2007 offset by the reduction
of the PSN's 2006 Part D liability.
Net cash used in investing activities for the nine months ended September 30,
2007 was approximately $1.2 million of which $591,000 was cash paid for the
acquisition of a physician practice and $617,000 related to capital expenditures
made during the first nine months of 2007.
Our financing activities for the nine months ended September 30, 2007 provided
approximately $249,000 of cash in connection with the issuance of common stock
upon the exercise of outstanding options.
We have a line of credit that expires on March 31, 2008, and provides for
borrowing up to $1.0 million. The outstanding balance, if any, bears interest at
the bank's prime rate. If we have outstanding borrowings under the credit
facility we are required to comply with certain financial covenants, including a
minimum liquidity requirement of $2.0 million. The availability under the line
of credit secures a $1.0 million letter of credit issued in favor of Humana. We
have not utilized this line at anytime in 2007.
Our HMO has required and continues to require a considerable amount of capital.
We contributed approximately $8.5 million to the HMO during 2006 and another
$14.5 million through September 30, 2007 to finance the operations and growth of
the HMO. We believe that in 2008, the HMO's business will continue to generate a
loss before allocated overhead and income taxes. We are continuing to commit
resources in an effort to increase our HMO customer base. The HMO's actual cash
needs and losses for 2008 are expected to be strongly influenced by, among other
things, the HMO's customer base, operating costs and Medical Expense Ratio as
well as the scale, cost and effectiveness of various marketing programs we may
undertake. In July 2007, we restructured our operations to better match the
current size of the HMO. We are still not in a position to meaningfully estimate
when, if ever, the HMO's business will become profitable and/or generate cash
from operations. We may be required to fund the development and expansion of the
HMO business, including any associated losses, for an extended period of time.
Nonetheless, we anticipate that the on-going development efforts, reserve
requirements and operating costs for our still developing HMO business can be
funded by our current resources and projected cash flows from operations until
at least December 31, 2008.
30
We have adopted a Company wide investment policy with respect to the investment
of our cash and equivalents. The goal of our investment policy is to obtain the
highest yield possible while investing only in highly rated instruments or
investments with nominal risk of loss of principal. The investment policy sets
forth a list of "Permitted Investments" and provides that the Chief Financial
Officer or the Chief Executive Officer must approve any exceptions to the
policy.
OFF-BALANCE SHEET ARRANGEMENTS
We do not have any Off-Balance Sheet Arrangements that have or are reasonably
likely to have a current or future effect on our financial condition, changes in
financial condition, revenues or expenses, results of operations, liquidity,
capital expenditures or capital resources that are material to investors.
ITEM 3A QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Market risk generally represents the risk of loss that may result from the
potential change in value of a financial instrument as a result of fluctuations
in interest rates and market prices. We do not currently have any trading
derivatives nor do we expect to have any in the future. We have established
policies and internal processes related to the management of market risks, which
we use in the normal course of our business operations.
Intangible Asset Risk
We have intangible assets and perform goodwill impairment tests annually and
whenever events or circumstances indicate that the carrying value may not be
recoverable from estimated future cash flows. As a result of our periodic
evaluations, we may determine that the intangible asset values need to be
written down to their fair values, which could result in material charges that
could be adverse to our operating results and financial position. We evaluate
the continuing value of goodwill by using valuation techniques based on
multiples of earnings, revenue, EBITDA (i.e., earnings before interest, taxes,
depreciation and amortization) particularly with regard to entities similar to
us that have recently been acquired. We also consider the market value of our
own stock and those of companies similar to ours. At September 30, 2007, we
believe our intangible assets are recoverable, however, changes in the economy,
the business in which we operate and our own relative performance could change
the assumptions used to evaluate intangible asset recoverability. We continue to
monitor those assumptions and their effect on the estimated recoverability of
our intangible assets.
Equity Price Risk
We do not own any equity investments, other than in our subsidiaries. As a
result, we do not currently have any direct equity price risk.
Commodity Price Risk
We do not enter into contracts for the purchase or sale of commodities. As a
result, we do not currently have any direct commodity price risk.
ITEM 4. CONTROLS AND PROCEDURES
Under the supervision and with the participation of our Chief Executive Officer,
or CEO, and our Chief Financial Officer, or CFO, we carried out an evaluation of
the effectiveness of the design and operation of our disclosure controls and
procedures for the period ended September 30, 2007.
Based on our evaluation, our CEO and CFO concluded that our disclosure controls
and procedures are effective to ensure that the information required to be
disclosed by us in the reports that we file or submit under the Securities
Exchange Act of 1934 is recorded, processed, summarized and reported within the
time periods specified in SEC rules and forms.
There have been no changes in our internal control over financial reporting that
occurred during our last fiscal quarter that have materially affected, or are
reasonably likely to materially affect, our internal control over financial
reporting.
31
PART II OTHER INFORMATION
ITEM 1A. RISK FACTORS
There have been no material changes in our risk factors from those disclosed in
our Annual Report on Form 10-K for the fiscal year ended December 31, 2006 other
than as set forth below.
The following text supplements the risk factors described in our Form 10-K for
the fiscal year ended December 31, 2006 under the heading "Risk Factors - There
Can be No Assurance that We Will be Successful in Our Operation of the HMO".
There Can be No Assurance that We Will be Successful in Our Operation of the
HMO.
To successfully operate the HMO, we believe we will need to reduce its medical
expenses and other operating costs as a percentage of revenue and continue to
develop the following capabilities, among others: sales and marketing, medical
management, customer service and regulatory compliance. No assurances can be
given that we will be successful in such endeavors or in operating this segment
of our business despite our allocation of a substantial amount of resources for
this purpose.
The HMO's actual cash needs and losses for the remainder of 2007 are expected to
be strongly influenced by, among other things, the HMO's customer base,
operating costs and Medical Expense Ratio as well as the scale, cost and
effectiveness of various marketing programs we may undertake.
ITEM 6. EXHIBITS
3.1. Articles of Incorporation, as amended (1)
3.2 Amended and Restated Bylaws (2)
10.1 Physician Practice Management Participation Agreement, dated August 2,
2001, between Metropolitan of Florida, Inc. and Humana, Inc. (3)
10.2. Letter of Agreement, dated February 2003, between Metropolitan of Florida,
Inc. and Humana, Inc. (4)
10.3. Physician Practice Management Participation Agreement, dated December 1,
1998, between Metcare of Florida, Inc. and Humana, Inc.(5)
10.4. Supplemental Stock Option Plan (6)
10.5. Omnibus Equity Compensation Plan (7)
10.6. Amended and Restated Employment Agreement between Metropolitan and Michael
M. Earley dated January 3, 2005 (9)
10.7. Amended and Restated Employment Agreement between Metropolitan and Robert
J. Sabo dated November 9, 2006 (10)
10.8. Amended and Restated Employment Agreement between Metropolitan and Roberto
L. Palenzuela dated January 3, 2005 (9)
10.9 Employment Agreement between Metcare of Florida, Inc. and Jose A. Guethon,
M.D. (5)
10.10. Form of Option Award Agreement for Option Grants to Directors pursuant to
the Omnibus Compensation Plan (5)
10.11. Form of Option Award Agreement for Option Grants to Key Employees
pursuant to the Omnibus Compensation Plan (5)
10.12. Form of Option Award Agreement for Option Grants to Employees pursuant to
the Omnibus Compensation Plan (5)
10.13. Agreement between Metcare of Florida, Inc. and the Centers for Medicare
and Medicaid Services (5)
10.14. Transition and Severance Agreement between Metropolitan and David S.
Gartner, dated August 18, 2006. (11)
10.15 Transition and Severance Agreement between Metropolitan and Debra A.
Finnel, dated April 9, 2007 (12)
10.16 Summary of 2007 Annual Bonus Plan for Executive Officers and certain key
management employees (13)
10.17 Summary of 2007 Director Compensation Plan*
10.18 Form of Restricted Stock Award Agreement for Restricted Stock Grants to
Directors pursuant to the Omnibus Compensation Plan*
10.19 Form of Restricted Stock Award Agreement for Restricted Stock Grants to
Management pursuant to the Omnibus Compensation Plan*
32
31.1. Certification of the Chief Executive Officer pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002*
31.2. Certification of the Chief Financial Officer pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002*
32.1. Certification of the Chief Executive Officer and the Chief Financial
Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
----------------------------------
* filed herewith
** furnished herewith
(1) Incorporated by reference to Metropolitan's Registration Statement on Form
8-A12B filed with the Commission on November 19, 2004 (No. 001-32361).
(2) Incorporated by reference to Metropolitan's Current Report on Form 8-K filed
with the Commission on September 30, 2004.
(3) Incorporated by reference to Metropolitan's Amendment to Registration
Statement on Form SB-2/A filed with the Commission on August 2,. 2001 (No.
333-61566). Portions of this document were omitted and were filed separately
with the SEC on or about August 2, 2001 pursuant to a request for confidential
treatment.
(4) Incorporated by reference to Metropolitan's Amendment to Annual Report for
the year ended December 31, 2003 on Form 10-K/A filed with the Commission on
July 28, 2004. Portions of this document have been omitted and were filed
separately with the SEC on July 28, 2004 pursuant to a request for confidential
treatment.
(5) Incorporated by reference to our Annual Report on Form 10-K for the year
ended December 31, 2005, as filed with the Commission on March 16, 2006.
(6) Incorporated by reference to Metropolitan's Amendment to Annual Report for
the year ended December 31, 2003 on Form 10-K/A filed with the Commission on
July 28, 2004.
(7) Incorporated by reference to Metropolitan's Registration Statement on Form
S-8 filed with the Commission on February 24, 2005 (No. 333-122976).
(8) Incorporated by reference to our Annual Report on Form 10-K for the year
ended December 31, 2003, as filed with the Commission on March 22, 2004.
(9) Incorporated (by reference to our Annual Report on Form 10-K for the year
ended December 31, 2004, as filed with the Commission on March 22, 2005.
(10) Incorporated by reference to Metropolitan's Current Report on Form 8-K
filed with the Commission on October 20, 2006.
(11) Incorporated by reference to Metropolitan's Current Report on Form 8-K
filed with the Commission on August 18, 2006.
(12) Incorporated by reference to Metropolitan's Current Report on Form 8-K
filed with the Commission on April 9, 2007.
(13) Incorporated by reference to Metropolitan's Current Report on Form 8-K
filed with the Commission on September 26, 2007.
33
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
Undersigned thereunto duly authorized.
METROPOLITAN HEALTH NETWORKS, INC.
Registrant
Date: November 6, 2007 /s/ Michael M. Earley
---------------------
Michael M. Earley
Chairman, Chief Executive Officer
/s/ Robert J. Sabo
Robert J. Sabo
Chief Financial Officer
34